News & Publications
Stanford Medicine News: Cancer
Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.
Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.
Some breast cancers return decades later. Now, a researcher at Stanford, joined by collaborators at several other institutions, has subcategorized tumors to predict recurrence, guide treatment decisions and improve drug development.
The researchers found that by testing for fragments of cancer DNA in urine, they could find the cancer in early stages of development, when it’s easier to treat.
A quarterly publication for patients and friends of the Stanford Cancer Institute.